No abstract available
MeSH terms
-
Blood Platelets / drug effects
-
Bridged-Ring Compounds / pharmacology
-
Bridged-Ring Compounds / therapeutic use*
-
Clinical Trials, Phase III as Topic
-
Humans
-
Janus Kinases / antagonists & inhibitors
-
Primary Myelofibrosis / drug therapy*
-
Primary Myelofibrosis / pathology
-
Pyrimidines / pharmacology
-
Pyrimidines / therapeutic use*
-
Spleen / drug effects
Substances
-
11-(2-pyrrolidin-1-ylethoxy)-14,19-dioxa-5,7,26-triazatetracyclo(19.3.1.1(2,6).1(8,12))heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene
-
Bridged-Ring Compounds
-
Pyrimidines
-
Janus Kinases